article · Egyptian Journal of Pathology
Background Laryngeal carcinoma represents the most common malignancy in otolaryngological surgical practice, accounting for about one-third of all malignancies of the head and neck region. The presence of lymph node metastasis (LNM) is considered the most important predictor of survival in head and neck squamous cell carcinomas, including laryngeal cancer. Objectives In this study, we aimed to identify histopathological and radiological parameters associated with LNM in laryngeal squamous cell carcinoma (LSCC). Patients and methods This retrospective study included a total of 89 cases of LSCC who underwent laryngectomy and neck dissection in Ain Shams University Hospital. A collection of clinicoradiologic and histopathologic data, as well as a review by two independent pathologists, was done. Results In univariate analysis, radiologic evidence of thyroid cartilage involvement, pathologically proven bilaterality, larger tumor size, grade, stage, lymphovascular and perineural invasion, and margin positivity were significantly associated with LNM ( P =0.037, P =0.011, P =0.034, P =0.004, P =0.005, P <0.00001, P =0.004, and P =0.02, respectively). Using multivariate analyses, tumor bilaterality, T stage, and perineural invasion were found to be independent risk factors for LNM, with T stage being the most significant predictor. Conclusion This study found that the most important histopathologic parameters related to cervical LNM from primary LSCC cases include tumor bilaterality, size, histologic grade, lymphovascular invasion, perineural invasion, margin clearance, and tumor stage. Radiologic evidence of thyroid cartilage invasion was also considered an independent risk factor.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/egjp.egjp_36_24
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.